114 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2013 ACCF/AHA Guideline ... American College of Cardiology ... Task Force on Clinical ... #ACCAHA2017 #cardiology ... #treatment #algorithm
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Recommendations for the Treatment ... Aspergillosis - IDSA Guidelines ... Aspergillosis #Treatment ... pharmacology #dosing #medications ... #IDSA #Guidelines
Immediate Treatment for Myocardial infraction
#management #pharmacology #medications #treatment #cardiology #mnemonic
Immediate Treatment ... #pharmacology #medications ... #treatment #cardiology
Recommended 1st-line Treatments for HIV

based on the guidelines by @AIDSinfo

 - Infographic by IDagram
@ID_agram

#HIV #Treatments #Medications
Recommended 1st-line Treatments ... based on the guidelines ... ID_agram #HIV #Treatments ... #Medications #Therapy
Sexually Transmitted Diseases: Summary of 2015 CDC Treatment Guidelines
These summary guidelines reflect the 2015 CDC Guidelines
Guidelines These ... summary guidelines ... reflect the 2015 CDC Guidelines ... as a source of clinical ... #Management #Guidelines
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... getting patients on medication ... both of these medications ... by the ACC/AHA guidelines ... #StageC #Cardiology
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
Treatment options ... Algorithm #Management #Cardiology ... #ivabradine #Medications
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... the use of this medication ... won’t have any clinical
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Managing BPD Clinical ... Practice Guideline ... with ‘treatment ... practice guideline1 ... Personality #Disorder #Medications
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #pharmacology #treatment ... #medications #table ... #decisionaid #cardiology